Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Scheen

Showing results (11-20 of 787) with videos related to

Pageof 79
Sort By:
Revue Medicale De Liege|November 20, 2010
[Saxagliptin (Onglyza): new inhibitor of the dipeptidylpeptidase-4 for the oral treatment of type 2 diabetes]A J Scheen
Revue Medicale De Liege|September 23, 2010
[A patient with cardiovascular risk factors and comorbidities: integration of indications and contra-indications in pharmacotherapy]A J Scheen
Revue Medicale Suisse|September 24, 2009
[What future for cardiovascular prevention trials?]A J Scheen
Revue Medicale De Liege|March 14, 2001
[Info-congress. Diabetes research: European diffusion from the Liege univesity]A J Scheen
Revue Medicale De Liege|February 24, 2001
[Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)]A J Scheen
Revue Medicale De Liege|April 19, 2000
[Clinical study of the month. The HOPE study, a two-by-two factorial clinical trial with contrasted results]A J Scheen
Revue Medicale De Liege|December 6, 2000
[Estrogen therapy after menopause and cardiovascular protection: discordance between epidemiologic observations and the results of therapeutic trials] A J Scheen
Revue Medicale De Liege|February 10, 2000
[Clinical study of the month. Does chronic sleep deprivation predispose to metabolic syndrome?]A J Scheen
Drug Safety|December 12, 2001
Hepatotoxicity with thiazolidinediones: is it a class effect?A J Scheen
Revue Medicale De Liege|October 1, 1995
[Clinical case of the month. Occupational rehabilitation of the diabetic patient]A J Scheen
Pageof 79

Showing results (11-20 of 787) with videos related to

Sort By:
Pageof 79
Revue Medicale De Liege|November 20, 2010
[Saxagliptin (Onglyza): new inhibitor of the dipeptidylpeptidase-4 for the oral treatment of type 2 diabetes]A J Scheen
Revue Medicale De Liege|September 23, 2010
[A patient with cardiovascular risk factors and comorbidities: integration of indications and contra-indications in pharmacotherapy]A J Scheen
Revue Medicale Suisse|September 24, 2009
[What future for cardiovascular prevention trials?]A J Scheen
Revue Medicale De Liege|March 14, 2001
[Info-congress. Diabetes research: European diffusion from the Liege univesity]A J Scheen
Revue Medicale De Liege|February 24, 2001
[Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)]A J Scheen
Revue Medicale De Liege|April 19, 2000
[Clinical study of the month. The HOPE study, a two-by-two factorial clinical trial with contrasted results]A J Scheen
Revue Medicale De Liege|December 6, 2000
[Estrogen therapy after menopause and cardiovascular protection: discordance between epidemiologic observations and the results of therapeutic trials] A J Scheen
Revue Medicale De Liege|February 10, 2000
[Clinical study of the month. Does chronic sleep deprivation predispose to metabolic syndrome?]A J Scheen
Drug Safety|December 12, 2001
Hepatotoxicity with thiazolidinediones: is it a class effect?A J Scheen
Revue Medicale De Liege|October 1, 1995
[Clinical case of the month. Occupational rehabilitation of the diabetic patient]A J Scheen
Pageof 79